• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. WEB SLS; INTRASACCULAR FLOW DISRUPTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. WEB SLS; INTRASACCULAR FLOW DISRUPTION DEVICE Back to Search Results
Model Number FG29040-001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Aneurysm (1708)
Event Date 02/02/2021
Event Type  Injury  
Manufacturer Narrative
A search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The device was implanted in the patient and not returned to the manufacturer for evaluation.Procedural images were not provided for review; therefore, the alleged product issue cannot be confirmed.
 
Event Description
It was reported that, on (b)(6) 2020, the patient received embolization treatment using a web sls for an aneurysm located in the left anterior cerebral artery.The aneurysm diagnosis was ruptured left anterior cerebral artery aneurysm with an h&h score i (date of rupture (b)(6) 2020).The angiographic result at the end of the procedure is a residual neck (raymond ii).Patient discharged (b)(6) 2020 with an mrs score 1, nihss score not performed.On (b)(6) 2021, almost seven months post procedure, the patient had a complication of apparition of new aneurysm near the neck (2mm diameter).According to the description provided by the site, the event is serious as it led to the patient hospitalization.The action taken in its regards is embolization with a fdv and the outcome is resolved without sequelae (b)(6) 2021.The relationship of the event is related to the study disease.Antiplatelet therapy was provided to the patient.The following medications were administrated: anticoagulant agent (heparin), asa, brillique, and sintrom.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WEB SLS
Type of Device
INTRASACCULAR FLOW DISRUPTION DEVICE
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key12130464
MDR Text Key260331548
Report Number2032493-2021-00273
Device Sequence Number1
Product Code OPR
UDI-Device Identifier00854111006174
UDI-Public(01)00854111006174(11)190204(17)220307(10)19020405
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P170032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Other
Type of Report Initial
Report Date 06/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/07/2022
Device Model NumberFG29040-001
Device Lot Number19020405
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/11/2021
Initial Date FDA Received07/07/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/04/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
-
-